Answer
Proton-pump inhibitors may reduce pemigatinib exposure in some people and should generally be avoided; ask the oncology pharmacist before using acid-suppressing treatment.
Sources for this answer
- Pemazyre 4.5 mg - tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.